Target type: biologicalprocess
Any process that activates or increases the frequency, rate or extent of inhibitory postsynaptic potential (IPSP). IPSP is a temporary decrease in postsynaptic membrane potential due to the flow of negatively charged ions into the postsynaptic cell. The flow of ions that causes an IPSP is an inhibitory postsynaptic current (IPSC) and makes it more difficult for the neuron to fire an action potential. [GOC:BHF, GOC:sjp, PMID:18550748]
Positive regulation of inhibitory postsynaptic potential is a crucial biological process involved in fine-tuning neuronal activity and shaping synaptic transmission. This process refers to the mechanisms that enhance the inhibitory postsynaptic potential (IPSP), a transient hyperpolarization of the postsynaptic membrane. The IPSP arises from the influx of negatively charged ions (primarily chloride) into the postsynaptic neuron, driven by the opening of chloride channels. These channels are typically activated by the binding of neurotransmitters released from presynaptic neurons. Positive regulation of this process can occur at various levels, from the presynaptic release of inhibitory neurotransmitters, like GABA or glycine, to the postsynaptic modulation of receptor activity, or changes in the expression of ion channels. Several key aspects contribute to the positive regulation of IPSP: 1) **Increased presynaptic neurotransmitter release:** Mechanisms like increased presynaptic calcium influx or enhanced vesicle fusion at the synapse can lead to a greater release of inhibitory neurotransmitters. 2) **Postsynaptic receptor modulation:** Up-regulation of postsynaptic receptors, like GABA receptors or glycine receptors, can increase the sensitivity of the postsynaptic neuron to inhibitory neurotransmitters. 3) **Enhanced chloride ion conductance:** Increased expression or activity of chloride channels in the postsynaptic membrane can augment the influx of chloride ions, thereby strengthening the IPSP. 4) **Modulation of intracellular signaling pathways:** Certain intracellular signaling pathways can influence the expression or activity of components involved in IPSP generation, such as neurotransmitter receptors or chloride channels. The positive regulation of inhibitory postsynaptic potential plays a critical role in various neurological processes, including: 1) **Synaptic plasticity:** By modulating the strength of inhibitory synapses, this process contributes to the dynamic adjustments in neuronal circuits that underlie learning and memory. 2) **Neural network activity:** Balancing excitatory and inhibitory input is essential for the proper functioning of neuronal networks. Positive regulation of IPSP helps control the overall excitation level in these networks. 3) **Sensory perception:** Inhibition is crucial for filtering out irrelevant sensory information, and positive regulation of IPSP can sharpen the perception of specific stimuli. 4) **Motor control:** The fine-tuning of motor commands relies on precise inhibitory control, which is influenced by the positive regulation of IPSP. 5) **Anxiety and mood:** Dysregulation of inhibitory neurotransmission has been linked to mood disorders, and therapies targeting the positive regulation of IPSP are being explored for treating these conditions. Understanding the intricate mechanisms underlying the positive regulation of inhibitory postsynaptic potential is crucial for advancing our knowledge of neuronal function and developing effective therapeutic strategies for neurological diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
4-aminobutyrate aminotransferase, mitochondrial | A 4-aminobutyrate aminotransferase, mitochondrial that is encoded in the genome of human. [PRO:DNx, UniProtKB:P80404] | Homo sapiens (human) |
Neurotensin receptor type 1 | A neurotensin receptor type 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P30989] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
gamma-aminobutyric acid | gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4. gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. | amino acid zwitterion; gamma-amino acid; monocarboxylic acid | human metabolite; neurotransmitter; Saccharomyces cerevisiae metabolite; signalling molecule |
4-hydroxybenzyl alcohol | 4-hydroxybenzyl alcohol: the aglycone of gastrodin p-hydroxybenzyl alcohol : A member of the class of benzyl alcohols that is benzyl alcohol substituted by a hydroxy group at position 4. It has been isolated from Arcangelisia gusanlung. | benzyl alcohols; phenols | plant metabolite |
4-hydroxybenzaldehyde | hydroxybenzaldehyde | EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor; mouse metabolite; plant metabolite | |
4-hydroxybenzoic acid | 4-hydroxybenzoic acid : A monohydroxybenzoic acid that is benzoic acid carrying a hydroxy substituent at C-4 of the benzene ring. | monohydroxybenzoic acid | algal metabolite; plant metabolite |
anthranilic acid | anthranilic acid : An aminobenzoic acid that is benzoic acid having a single amino substituent located at position 2. It is a metabolite produced in L-tryptophan-kynurenine pathway in the central nervous system. anthranilic acid: RN given refers to parent cpd; structure in Negwer, 5th ed, #565 | aminobenzoic acid | human metabolite; mouse metabolite |
4-aminobenzoic acid | 4-aminobenzoic acid : An aminobenzoic acid in which the amino group is para to the carboxy group. 4-Aminobenzoic Acid: An aminobenzoic acid isomer that combines with pteridine and GLUTAMIC ACID to form FOLIC ACID. The fact that 4-aminobenzoic acid absorbs light throughout the UVB range has also resulted in its use as an ingredient in SUNSCREENS. 4-ammoniobenzoate : A zwitterion obtained by transfer of a proton from the carboxy to the amino group of 4-aminobenzoic acid. | aminobenzoic acid; aromatic amino-acid zwitterion | allergen; Escherichia coli metabolite; plant metabolite |
vanillin | Vanilla: A plant genus of the family ORCHIDACEAE that is the source of the familiar flavoring used in foods and medicines (FLAVORING AGENTS). | benzaldehydes; monomethoxybenzene; phenols | anti-inflammatory agent; anticonvulsant; antioxidant; flavouring agent; plant metabolite |
vigabatrin | gamma-amino acid | anticonvulsant; EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor | |
4-hydroxypropiophenone | acetophenones | ||
3-aminobenzoic acid | 3-aminobenzoic acid : An aminobenzoic acid carrying an amino group at position 3. 3-aminobenzoic acid: RN given refers to parent cpd | aminobenzoic acid | |
4-hydroxyacetophenone | 4-hydroxyacetophenone: promotes secretion of bile & bile salts, which promotes griseofulvin absorption in the duodenum 4'-hydroxyacetophenone : A monohydroxyacetophenone carrying a hydroxy substituent at position 4'. | monohydroxyacetophenone | fungal metabolite; mouse metabolite; plant metabolite |
4-anisaldehyde | 4-anisaldehyde: RN given refers to cpd with specified locants for methoxy moieties; structure in Merck, 9th ed, #696 p-methoxybenzaldehyde : A member of the class of benzaldehydes consisting of benzaldehyde itself carrying a methoxy substituent at position 4. | benzaldehydes | bacterial metabolite; human urinary metabolite; insect repellent; plant metabolite |
4-hydroxybenzylamine | 4-hydroxybenzylamine: RN given refers to parent cpd | aromatic amine | |
gastrodin | gastrodin: the glucoside of 4-hydroxybenzyl alcohol (gastrodigenin); isolated from Gastrodia elata Blume; | glycoside | |
sr 48692 | SR 48692: structure in first source; a neurotensin receptor-1 antagonist | N-acyl-amino acid | |
baicalein | trihydroxyflavone | angiogenesis inhibitor; anti-inflammatory agent; antibacterial agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antioxidant; apoptosis inducer; EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; EC 4.1.1.17 (ornithine decarboxylase) inhibitor; ferroptosis inhibitor; geroprotector; hormone antagonist; plant metabolite; prostaglandin antagonist; radical scavenger | |
neurotensin | |||
sr 142948 | SR 142948: structurally similar to SR-48692 | N-acyl-amino acid | |
sr 48527 | SR 48527: SR 48527 is the S-enantiomer; SR-49711 is the R-enantiomer | ||
sr 142948a | SR 142948A: structure in first source | ||
4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl)-piperidine hydrogen chloride | |||
helicide | helicide: structure given in first source | glycoside | |
neurotensin | neurotensin, Tyr(11)-: RN given refers to parent cpd & (D)-isomer; RN for cpd without isomeric designation not avail 5/91 | peptide hormone | human metabolite; mitogen; neurotransmitter; vulnerary |
nitd 609 | NITD 609: an antimalarial and coccidiostat; structure in first source |